Latest Press Releases & News

Alessa Therapeutics announced the enrollment of the first two men with prostate cancer in the company’s Biolen+RT clinical study. Biolen+RT (NCT 04943536) is a Phase…

Alessa Therapeutics announced that it has entered into a research collaboration agreement with an affiliate of Janssen Research & Development, LLC. This agreement was facilitated by Johnson…

Alessa Therapeutics announced that the U.S. Food and Drug Administration (FDA) has accepted the Investigational New Drug application (IND) for Biolen®. Alessa, in collaboration with…